5th European Congress of Immunology
- Starts: Sep 02, 2018
- Ends: Sep 05, 2018
- Location: Amsterdam, Netherlands
- Venue: Amsterdam RAI Exhibition and Convention Centre
- Website: https://www.eci2018.org/home/
- E-mail: eci2018@medacad.org
Event Description
The 5th ECI will cover all fields of modern immunology, ranging from innate memory and tissue specific regulation of T and B cell differentiation to unsupervised analyses of big data for diagnostics and combinational immunomodulatory biologicals.
The special focus of the 5th ECI will be ‘Building Bridges’.
In the meeting the organizers will specifically dedicate sessions to identify new discoveries in fundamental immunology that hold diagnostic and therapeutic promise and to tackle challenges that arise from connecting fundamental and translational science.
The organizers will bring in scientists from interdisciplinary fields, like data management, systems biology and multidimensional systems imaging to form beachheads for novel directions of immunological research and optimised evaluations of clinical trials.
The program offers 150+ talks by invited speakers, with exemplary keynote lectures and state-of-the field presentations by top of the bill immunologists. The group of invited speakers contains not only established world-leading scientists in basic and translational immunology, but also front-runners in clinical immunomodulatory therapies and up-and-coming scientists, who are changing current immunological concepts through novel scientific approaches. To give ample exposure to exciting new data from the whole immunological society, more than 400 oral presentations will be selected from submitted abstracts.
The organizers aim to have poster sessions and guided poster walks that will allow strong exposure of all research and stimulate discussions and networking. Special attention will be devoted to the education of our young scientists and students. In addition, the 5th ECI will feature a number of satellite meetings dealing with related topics.
The special focus of the 5th ECI will be ‘Building Bridges’.
In the meeting the organizers will specifically dedicate sessions to identify new discoveries in fundamental immunology that hold diagnostic and therapeutic promise and to tackle challenges that arise from connecting fundamental and translational science.
The organizers will bring in scientists from interdisciplinary fields, like data management, systems biology and multidimensional systems imaging to form beachheads for novel directions of immunological research and optimised evaluations of clinical trials.
The program offers 150+ talks by invited speakers, with exemplary keynote lectures and state-of-the field presentations by top of the bill immunologists. The group of invited speakers contains not only established world-leading scientists in basic and translational immunology, but also front-runners in clinical immunomodulatory therapies and up-and-coming scientists, who are changing current immunological concepts through novel scientific approaches. To give ample exposure to exciting new data from the whole immunological society, more than 400 oral presentations will be selected from submitted abstracts.
The organizers aim to have poster sessions and guided poster walks that will allow strong exposure of all research and stimulate discussions and networking. Special attention will be devoted to the education of our young scientists and students. In addition, the 5th ECI will feature a number of satellite meetings dealing with related topics.
Purpose
T follicular helper cells, T follicular regulatory cells and autoimmunity
Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-γ signalling
Recent advances in viral evasion of the MHC Class I processing pathway
Triggering of TLR-3, -4, NOD2 and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies
Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-γ signalling
Recent advances in viral evasion of the MHC Class I processing pathway
Triggering of TLR-3, -4, NOD2 and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies